Showing results (1671-1680 of 8,346) with videos related to
Sort By:
Pageof 835
The New England Journal of Medicine|September 10, 1992
A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 GroupR H Mattson, J A Cramer, J F CollinsPhysical Review Letters|April 22, 2017
Thermalization and Return to Equilibrium on Finite Quantum Lattice SystemsTerry Farrelly, Fernando G S L Brandão, Marcus CramerJournal of Molecular Microbiology and Biotechnology|September 25, 2007
RamB is an activator of the pyruvate dehydrogenase complex subunit E1p gene in Corynebacterium glutamicumBastian Blombach, Annette Cramer, Bernhard J Eikmanns, et al.Journal of Computational Chemistry|October 5, 2006
Characterization of the structure and reactivity of monocopper-oxygen complexes supported by beta-diketiminate and anilido-imine ligandsBenjamin F Gherman, William B Tolman, Christopher J CramerJournal of Medicinal Chemistry|June 8, 2017
Paying the Price of Desolvation in Solvent-Exposed Protein Pockets: Impact of Distal Solubilizing Groups on Affinity and Binding Thermodynamics in a Series of Thermolysin InhibitorsJonathan Cramer, Stefan G Krimmer, Andreas Heine, et al.Journal of Inorganic Biochemistry|March 1, 1985
Effect of cyanide binding on the copper sites of cytochrome c oxidase: an X-ray absorption spectroscopic studyR A Scott, J R Schwartz, S P CramerPhysical Review. E, Statistical, Nonlinear, and Soft Matter Physics|July 13, 2004
Parametric instabilities in magnetized multicomponent plasmasM P Hertzberg, N F Cramer, S V VladimirovAmerican Journal of Health Promotion : AJHP|September 21, 2005
Assessing the walkability of the workplace: a new audit toolAndrew L Dannenberg, Todd W Cramer, Christopher J GibsonAnnals of Botany|October 19, 2007
Changes in photosynthetic rates and gene expression of leaves during a source-sink perturbation in sugarcaneA J McCormick, M D Cramer, D A WattStroke|March 3, 2007
The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agentsSteven C Cramer, Walter J Koroshetz, Seth P FinklesteinPageof 835